Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: the example of Alzheimer's disease.

Andrieux K, Couvreur P.

Ann Pharm Fr. 2013 Jul;71(4):225-33. doi: 10.1016/j.pharma.2013.04.001. Epub 2013 May 28. Review.

PMID:
23835020
2.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
3.

Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.

Kulkarni PV, Roney CA, Antich PP, Bonte FJ, Raghu AV, Aminabhavi TM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jan-Feb;2(1):35-47. doi: 10.1002/wnan.59. Review.

PMID:
20049829
4.

[Nanoparticles for brain delivery of drugs or contrast agents. Application to Alzheimer's disease].

Andrieux K, Couvreur P.

Biol Aujourdhui. 2012;206(3):185-90. doi: 10.1051/jbio/2012019. Epub 2012 Nov 22. Review. French.

PMID:
23171841
5.

[Alzheimer disease: cellular and molecular aspects].

Octave JN.

Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. French.

PMID:
16768248
6.

Nanotechnology and Alzheimer's disease: what has been done and what to do.

Ruozi B, Belletti D, Pederzoli F, Veratti P, Forni F, Vandelli MA, Tosi G.

Curr Med Chem. 2014;21(36):4169-85. Review.

PMID:
25039777
7.

[Alzheimer's disease: new prospects in therapy and applied experimental models].

Kubis AM, Janusz M.

Postepy Hig Med Dosw (Online). 2008 Aug 5;62:372-92. Review. Polish.

8.
9.

Beta-amyloid, neuronal death and Alzheimer's disease.

Carter J, Lippa CF.

Curr Mol Med. 2001 Dec;1(6):733-7. Review.

PMID:
11899259
10.

Nanomedicine for the treatment of Alzheimer's disease.

Gregori M, Masserini M, Mancini S.

Nanomedicine (Lond). 2015;10(7):1203-18. doi: 10.2217/nnm.14.206. Review.

PMID:
25929574
11.

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.

Bhaskar S, Tian F, Stoeger T, Kreyling W, de la Fuente JM, Grazú V, Borm P, Estrada G, Ntziachristos V, Razansky D.

Part Fibre Toxicol. 2010 Mar 3;7:3. doi: 10.1186/1743-8977-7-3. Review.

13.

[Blood-brain barrier and Alzheimer's disease].

Kuwahara H, Nishida Y, Yokota T.

Brain Nerve. 2013 Feb;65(2):145-51. Review. Japanese.

PMID:
23399672
14.

Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.

Cho JE, Kim JR.

Recent Pat CNS Drug Discov. 2011 Sep 1;6(3):222-33. Review.

PMID:
21834780
15.

Neurotherapeutic applications of nanoparticles in Alzheimer's disease.

Sahni JK, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C.

J Control Release. 2011 Jun 10;152(2):208-31. doi: 10.1016/j.jconrel.2010.11.033. Epub 2010 Dec 4. Review.

PMID:
21134407
16.

Beyond the neurotransmitter-focused approach in treating Alzheimer's disease: drugs targeting beta-amyloid and tau protein.

Panza F, Solfrizzi V, Frisardi V, Imbimbo BP, Capurso C, D'Introno A, Colacicco AM, Seripa D, Vendemiale G, Capurso A, Pilotto A.

Aging Clin Exp Res. 2009 Dec;21(6):386-406. Review.

PMID:
20154508
17.

Adult neurogenesis: a potential tool for early diagnosis in Alzheimer's disease?

Lopez-Toledano MA, Ali Faghihi M, Patel NS, Wahlestedt C.

J Alzheimers Dis. 2010;20(2):395-408. doi: 10.3233/JAD-2010-1388. Review.

PMID:
20164555
18.

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

Chen Z, Zhong C.

Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11. Review.

19.

Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.

Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A.

Immunotherapy. 2012 Feb;4(2):213-38. doi: 10.2217/imt.11.170. Review.

PMID:
22339463
20.

Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.

Conway KA, Baxter EW, Felsenstein KM, Reitz AB.

Curr Pharm Des. 2003;9(6):427-47. Review.

PMID:
12570807
Items per page

Supplemental Content

Write to the Help Desk